{"id":8597,"date":"2024-07-29T12:06:21","date_gmt":"2024-07-29T11:06:21","guid":{"rendered":"https:\/\/blog.caixaresearch.org\/?p=8597"},"modified":"2024-07-29T14:15:07","modified_gmt":"2024-07-29T13:15:07","slug":"5-key-insights-into-the-future-of-biomedical-innovation-in-portugal","status":"publish","type":"post","link":"https:\/\/blog.caixaresearch.org\/ca\/5-key-insights-into-the-future-of-biomedical-innovation-in-portugal\/","title":{"rendered":"5 key insights into the future of biomedical innovation in Portugal"},"content":{"rendered":"<p><em><strong>Catalan below<\/strong><\/em><\/p>\n<p><iframe loading=\"lazy\" title=\"YouTube video player\" src=\"https:\/\/www.youtube.com\/embed\/oVfg1bsx18I?si=C5pKvwuz_FeoFn89\" width=\"400\" height=\"225\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<p>In recent years, the output from Portugal\u2019s biomedical research has been steadily increasing. However, the innovation ecosystem is still developing and there are diverse systemic challenges to overcome to ensure the efficient translation of biomedical research into clinical applications.<\/p>\n<p>On July 10, <strong>we organized an <a href=\"https:\/\/caixaresearch.org\/es\/innovation-day-portugal-introduction\">event<\/a> in Lisbon that brought together some of Portugal\u2019s top biomedical researchers and entrepreneurs, decision-makers and international experts to discuss the challenges and opportunities in bringing scientific discoveries from the lab to the clinic<\/strong>.<\/p>\n<p>The event, inaugurated by Artur Santos Silva, Member of the Board of Trustees of \u201dla Caixa\u201d Foundation and Fernando Alexandre, Portugal\u2019s Minister of Education, Science and Innovation, included several keynote speeches and two roundtable discussions, with researchers-turned-entrepreneurs sharing their journeys and offering suggestions to bolster Portugal\u2019s biomedical innovation ecosystem.<\/p>\n<p><iframe loading=\"lazy\" title=\"YouTube video player\" src=\"https:\/\/www.youtube.com\/embed\/imqAgS5L5UA?si=i2Ue4vVgyT9fSWDE\" width=\"400\" height=\"225\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<p>Here are the key takeaways from these discussions:<\/p>\n<h3>1. There is still huge untapped potential in biomedical innovation.<\/h3>\n<p>Portugal&#8217;s biomedical research has experienced remarkable growth in recent years. \u201cBetween 2010 and 2023, the number of research publications in biomedicine increased by 177%, outpacing Spain and other EU countries\u201d explained Ignasi L\u00f3pez, Director of Partnerships with Research and Health Institutions, \u201dla Caixa\u201d Foundation. Yet despite this significant expansion, technology transfer and innovation have not grown proportionally (For more details, see <a href=\"https:\/\/caixaresearch.org\/documents\/387182\/1279249\/innovation-day-portugal-fostering-biomedical-innovation-2024.pdf\">his presentation<\/a> summarizing key statistics on the growth and impact of biomedical research in Portugal from 2010 to 2023). \u201cThere are many structural problems that need to be addressed to increase Portugal\u2019s output in innovation\u201d said Manuel Heitor, Director of <a href=\"https:\/\/in3.dem.ist.utl.pt\/\">Technology Policy Lab<\/a> and former Minister of Science, Technology and Higher Education in Portugal.<\/p>\n<p><a href=\"https:\/\/caixaresearch.org\/en\/caixaresearch-consolidate-call-2020-project-cancer-ctc\">Lorena Di\u00e9guez<\/a>, researcher at the <a href=\"https:\/\/www.inl.int\/\">Laboratorio Ib\u00e9rico Internacional de Nanotecnolog\u00eda (INL)<\/a>, added that \u201cthere are numerous barriers preventing the translation of healthcare research\u201d, elaborating that there is often a lack of incentives and support for researchers to transfer their discoveries. \u201cAddressing these challenges is crucial to foster effective scientific advancement and innovation\u201d she added.<\/p>\n<p>The <a href=\"https:\/\/caixaresearch.org\/en\/caixaimpulse-health-innovation-call\">CaixaImpulse Innovation<\/a> programme was designed to address this \u201cvalley of death\u201d that many projects fall into but such initiatives are just the beginning. Portugal should take its cue from more developed innovation ecosystems abroad which have created a structured path that safeguards projects against failure. During the first roundtable discussion, <a href=\"https:\/\/caixaresearch.org\/en\/caixaresearch-health-call-2019-project-cancer-defences\">Bruno Silva-Santos<\/a>, researcher at the <a href=\"https:\/\/imm.medicina.ulisboa.pt\/\">Instituto de Medicina Molecular (iMM)<\/a>, shared his experience of this. \u201cOur company received around \u20ac300,000 in funding in Portugal but, once acquired by a UK company, it attracted \u20ac2 million from the first investor and they instantly set up a board of directors with experts in diverse fields, so the company couldn\u2019t fail. It eventually received \u20ac98 million more in funding. The science was entirely Portuguese but it was the UK ecosystem that enabled it to thrive&#8221;. <strong>This underscores the need for Portugal to develop a robust ecosystem that supports not just excellent research but also scientific translation, with better funding and infrastructure.<\/strong><\/p>\n<p><iframe loading=\"lazy\" title=\"YouTube video player\" src=\"https:\/\/www.youtube.com\/embed\/bvXjUV_4L7k?si=cOKsAeJRqWaxQ4HX\" width=\"400\" height=\"225\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<h3>2. The key to innovation lies in breaking down silos whilst maintaining diversity.<\/h3>\n<p>Many of the biggest challenges we face as a society are structural and we therefore need structural approaches, funds and solutions to address them. However, these structural issues also often hinder research and innovation output. Resolving such problems requires breaking down disciplinary silos and adopting a broader view of science to uncover new connections and approaches.<\/p>\n<p>As Nuno Sousa, President of the <a href=\"https:\/\/aicib.pt\/en\/inicio-aicib-english-2\/\">Ag\u00eancia de Investiga\u00e7\u00e3o Cl\u00ednica e Inova\u00e7\u00e3o (AICIB)<\/a>, pointed out, \u201c<strong>collaborations and partnerships, among both scientific and non-scientific entities, are essential in order to build capacity and achieve critical mass<\/strong>\u201d. This is especially true in a country like Portugal, which has a population of just 10 million. Yet, at the same time, maintaining diversity through individual contributions and competition is equally crucial. \u201c<strong>While Europe lags behind China and the US in scientific output, it boasts a more robust and diversified knowledge base than its counterparts. This should serve as a wake-up call for Europe. To maximise its innovative impact, Portugal must adopt an EU-level perspective on innovation, whilst also fostering diverse innovations locally<\/strong>\u201d explained Manuel Heitor.<\/p>\n<p>Even at a national and regional level, \u201c<strong>collaboration and strategic mergers are important but Portuguese institutions must also pursue their own unique paths to ensure the ongoing cultivation of diverse ideas and innovations<\/strong>\u201d said <a href=\"https:\/\/caixaresearch.org\/en\/caixaresearch-health-call-2023-project-plasmodium-malaria\">Mar\u00eda Mota<\/a>, Executive President of the <a href=\"https:\/\/gimm.pt\/\">Gulbenkian Institute for Molecular Medicine (GIMM)<\/a>.<\/p>\n<p><iframe loading=\"lazy\" title=\"YouTube video player\" src=\"https:\/\/www.youtube.com\/embed\/g0YZk3mTKaM?si=ceqdxImTB58mnxKy\" width=\"400\" height=\"225\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<h3>3. <b>It takes a village: the responsibility of biomedical innovation must be shared.<\/b><\/h3>\n<p>Traditionally, scientists have been expected not only to carry out research but also to bring their discoveries to the market single-handedly. \u201cScientists are expected to wear many hats\u201d pointed out <a href=\"https:\/\/caixaresearch.org\/en\/caixaresearch-health-call-2022-project-biopharmaceuticals-virus\">Cl\u00e1udio M. Soares<\/a>, from <a href=\"https:\/\/www.itqb.unl.pt\/\">ITQB NOVA<\/a>. However, <strong>starting up a company is extremely difficult and scientists need much more support \u2014 both financial and non-financial \u2014 as they focus on building their companies<\/strong>. Lorena Di\u00e9guez noted \u201cI used to think that, if the science was great, someone else would take over the project and develop the startup. I now know the onus is on the scientist to push the prototype and convince investors. Without initiatives like the CaixaImpulse Innovation call, many projects would fail due to the enormous funding required from initial proof of concept to venture capital investment\u201d.<\/p>\n<p><strong>The commercialisation of biomedical research should be a shared responsibility between scientists, healthcare systems, industry, government and other stakeholders.<\/strong> \u201cWe need to make it easier for scientists to hand off their knowledge to those capable of scaling it into successful enterprises\u201d said Nuno Sousa. Even long before external entities come into the picture, research institutes need to provide infrastructures to support researchers interested in entrepreneurship. \u201c<strong>Tech transfer offices at universities are crucial; without them, scientists might not even consider commercialising their research. When researchers know there&#8217;s institutional support to guide them through the applications, steps and processes, they&#8217;re more likely to attempt to transfer their results<\/strong>\u201d said Bruno Silva-Santos. There should always be someone to demystify the journey for would-be entrepreneurs and assist them in taking the necessary steps. Experienced researcher-entrepreneurs can serve as crucial mentors for those embarking on or contemplating this path.<\/p>\n<p><iframe loading=\"lazy\" title=\"YouTube video player\" src=\"https:\/\/www.youtube.com\/embed\/IkR6Gn2I8wc?si=hKK9styE9uua4SdI\" width=\"400\" height=\"225\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<h3>4. We need to give scientists more opportunities to train in entrepreneurship.<\/h3>\n<p>Scientists are inherently innovative but are primarily trained to carry out research, not to start up businesses. <strong>It&#8217;s therefore crucial to provide them with opportunities to participate in intensive tech transfer training schemes that teach entrepreneurship, such as the CaixaImpulse Innovation programme<\/strong>. Establishing an entrepreneurial culture should begin with early education, equipping students with the necessary tools to promote innovation. In\u00eas C. Gon\u00e7alves, from the <a href=\"https:\/\/www.i3s.up.pt\/\">Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade (i3S) | Instituto de Engenharia Biom\u00e9dica (INEB), Universidade do Porto<\/a>, explained her own experience. \u201cTwenty years ago, I took a course in entrepreneurship and it completely transformed my approach to science. Since then, I&#8217;ve consistently focused on translating research results into clinical applications\u201d. Such training can also help combat the brain drain. \u201cMany Portuguese PhD students go abroad and don&#8217;t return because conditions and opportunities for growth and support are better elsewhere\u201d pointed out Cl\u00e1udio M. Soares. Scientists desire the freedom to be creative but they also need excellent conditions and supportive infrastructure, whether they choose an entrepreneurial path or another career trajectory.<\/p>\n<p><iframe loading=\"lazy\" title=\"YouTube video player\" src=\"https:\/\/www.youtube.com\/embed\/mgq0qGnT-IQ?si=QGdr41Dd3huP6Wmh\" width=\"400\" height=\"225\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<h3>5. Long-term innovation requires a broad, sustained investment approach.<\/h3>\n<p>Long-term innovation depends on continuous investment in basic research. While tech transfer and immediate innovations are important, the breakthroughs of the future rely on today&#8217;s fundamental science. \u201c<strong>The heart of this ecosystem is fundamental research \u2014 we can\u2019t forget that<\/strong>\u201d said Claudio Sunkel, Director of the Institute for Research and Innovation in Health (i3S) at the Universidade do Porto. \u201cThe system needs to be enlarged to provide the material to be translated; if the raw material isn\u2019t there, there won\u2019t be innovation\u201d stressed <a href=\"https:\/\/caixaresearch.org\/en\/caixaresearch-health-call-2019-project-sepsis\">Miguel C. Parreira Soares<\/a>, from the <a href=\"https:\/\/gulbenkian.pt\/ciencia\/\">Instituto Gulbenkian de Ci\u00eancia (IGC)<\/a>.<\/p>\n<p>\u00c0ngel Font, Executive Director of the <a href=\"https:\/\/lacaixafoundation.org\/en\/\">CaixaResearch Institute<\/a> and Research and Health in Portugal, added that \u201cwithout excellent science, we can&#8217;t generate new treatments, technologies or solutions to society&#8217;s most important problems.\u201d<\/p>\n<p>\u201cIt&#8217;s important to collaborate closely with industry and develop a strategic roadmap for the next ten to twenty years\u201d commented Catarina Resende de Oliveira, from the <a href=\"https:\/\/cnc.uc.pt\/en\">Center for Neuroscience and Cell Biology (CNC)<\/a>, University of Coimbra.<\/p>\n<p>Pedro Pita, the BPI | Funda\u00e7\u00e3o &#8220;la Caixa&#8221; Chair in Health Economics at the Nova School of Business and Economics, in charge of the wrap-up session, summarized the key takeaways, emphasised the critical need to address the fragmentation of funding across various phases of innovation in Portugal. &#8220;How do we overcome this? It&#8217;s essential to have a clear vision of the path ahead and to strategically allocate limited resources among different research groups and areas. We need a more structured approach, rather than relying on luck&#8221; he stated.<\/p>\n<p>\u201cEstablishing milestones that facilitate collaboration between researchers, entrepreneurs and industry is essential to promote innovation \u2014 and collaboration between academia, industry and government is paramount to achieving this\u201d concluded Juan Ram\u00f3n Fuertes, Deputy General Manager of \u201dla Caixa\u201d Foundation.<\/p>\n<p>&nbsp;<\/p>\n<p><em>Innovation will only thrive if we foster it together. For our researchers, innovation is about improving health, creating value for society and transforming ideas into life-saving solutions. For us, it&#8217;s clear: innovation is about building a better future for everyone. What does innovation mean to you?<\/em><\/p>\n<p><iframe loading=\"lazy\" title=\"YouTube video player\" src=\"https:\/\/www.youtube.com\/embed\/3JRdrEp6RL4?si=zgvAcCn1_0NmwGwJ\" width=\"400\" height=\"225\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<p><em>&#8220;la Caixa&#8221; Foundation has been supporting research and innovation in biomedicine and health in Portugal since 2017 through its CaixaResearch Health and CaixaImpulse Innovation calls. Find out more about its impact in this video:<\/em><\/p>\n<p><iframe loading=\"lazy\" title=\"YouTube video player\" src=\"https:\/\/www.youtube.com\/embed\/HKDlapMWsCY?si=62u_kIsEHiP841Qa\" width=\"400\" height=\"225\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<p>&nbsp;<\/p>\n<p><em><strong>[Catalan]<\/strong><\/em><\/p>\n<h1>Cinc idees clau sobre el futur de la innovaci\u00f3 biom\u00e8dica a Portugal.<\/h1>\n<p><iframe loading=\"lazy\" title=\"YouTube video player\" src=\"https:\/\/www.youtube.com\/embed\/oVfg1bsx18I?si=C5pKvwuz_FeoFn89\" width=\"400\" height=\"225\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<p>Els \u00faltims anys, la recerca biom\u00e8dica duta a terme a Portugal ha experimentat un creixement constant. Tanmateix, l\u2019ecosistema d\u2019innovaci\u00f3 portugu\u00e8s es troba encara en desenvolupament i presenta alguns reptes sist\u00e8mics que cal superar per garantir una transfer\u00e8ncia efica\u00e7 entre la recerca biom\u00e8dica i les aplicacions cl\u00edniques.<\/p>\n<p>El 10 de juliol, <strong>vam organitzar un <a href=\"https:\/\/caixaresearch.org\/ca\/innovation-day-portugal-introduction\">esdeveniment<\/a> a Lisboa que va reunir alguns dels investigadors i emprenedors principals del sector biom\u00e8dic lusit\u00e0, i tamb\u00e9 responsables pol\u00edtics i experts internacionals, amb la finalitat d\u2019analitzar els reptes i les oportunitats que planteja la translaci\u00f3 dels descobriments cient\u00edfics des del laboratori fins a la pr\u00e0ctica cl\u00ednica<\/strong>.<\/p>\n<p>L\u2019esdeveniment, inaugurat per Artur Santos Silva, membre del Patronat de la Fundaci\u00f3 \u201dla Caixa\u201d, i Fernando Alexandre, ministre d\u2019Educaci\u00f3, Ci\u00e8ncia i Innovaci\u00f3 de Portugal, es va anar desplegant a trav\u00e9s de diverses pon\u00e8ncies i dues taules rodones, en les quals diferents investigadors esdevinguts emprenedors van compartir les seves experi\u00e8ncies i van fer suggeriments per potenciar l\u2019ecosistema d\u2019innovaci\u00f3 biom\u00e8dica de Portugal.<\/p>\n<p><iframe loading=\"lazy\" title=\"YouTube video player\" src=\"https:\/\/www.youtube.com\/embed\/imqAgS5L5UA?si=i2Ue4vVgyT9fSWDE\" width=\"400\" height=\"225\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<p>A continuaci\u00f3 es detallen les conclusions principals d\u2019aquestes taules rodones:<\/p>\n<h3>1. Hi ha encara un enorme potencial sense explotar en innovaci\u00f3 biom\u00e8dica.<\/h3>\n<p>La recerca biom\u00e8dica duta a terme a Portugal ha experimentat un creixement important els \u00faltims anys. \u00abEntre el 2010 i el 2023, el nombre de publicacions de recerca biom\u00e8dica va augmentar un 177 %, xifra superior a la d\u2019Espanya i altres pa\u00efsos de la UE\u00bb, va explicar Ignasi L\u00f3pez, director de l\u2019\u00c0rea de Relacions amb Institucions d\u2019Investigaci\u00f3 i Salut de la Fundaci\u00f3 \u201dla Caixa\u201d. Tanmateix, tot i aquest important desenvolupament, la transfer\u00e8ncia de tecnologia i la innovaci\u00f3 no han crescut de la mateixa manera (per a m\u00e9s detalls, vegeu <a href=\"https:\/\/caixaresearch.org\/documents\/387182\/1279249\/innovation-day-portugal-fostering-biomedical-innovation-2024.pdf\">la seva presentaci\u00f3<\/a> resumint estad\u00edstiques clau sobre el creixement i l&#8217;impacte de la recerca biom\u00e8dica a Portugal des del 2010 fins al 2023). \u00abS\u2019han d\u2019abordar molts problemes estructurals perqu\u00e8 Portugal pugui produir m\u00e9s innovaci\u00f3\u00bb, va indicar Manuel Heitor, director del <a href=\"https:\/\/in3.dem.ist.utl.pt\/\">Technology Policy Lab<\/a> i exministre de Ci\u00e8ncia, Tecnologia i Educaci\u00f3 Superior de Portugal.<\/p>\n<p><a href=\"https:\/\/caixaresearch.org\/ca\/convocatoria-caixaresearch-consolidate-2020-projecte-cancer-ctc\">Lorena Di\u00e9guez<\/a>, investigadora del <a href=\"https:\/\/www.inl.int\/\">Laboratorio Ib\u00e9rico Internacional de Nanotecnolog\u00eda (INL)<\/a>, va afegir que \u00abhi ha nombrosos obstacles que impedeixen la translaci\u00f3 de la recerca sanit\u00e0ria\u00bb. En concret, a m\u00e9s, va indicar que sovint falten incentius i ajuts perqu\u00e8 els investigadors puguin traslladar els seus descobriments a la pr\u00e0ctica cl\u00ednica. I va concloure que \u00ababordar aquests reptes \u00e9s crucial per poder fomentar la innovaci\u00f3 i els aven\u00e7os cient\u00edfics d\u2019una manera efectiva\u00bb.<\/p>\n<p>El programa <a href=\"https:\/\/caixaresearch.org\/ca\/convocatoria-caixaimpulse-innovacio-salut\">CaixaImpulse Innovaci\u00f3<\/a> s\u2019ha dissenyat per posar remei a aquesta \u00abvall de la mort\u00bb en qu\u00e8 cauen molts projectes. Per\u00f2 aquestes iniciatives s\u00f3n nom\u00e9s el principi. Portugal hauria de seguir l\u2019exemple d\u2019ecosistemes d\u2019innovaci\u00f3 m\u00e9s desenvolupats, existents en altres pa\u00efsos, que han creat una estrat\u00e8gia estructurada per evitar que els projectes fracassin. Durant la primera taula rodona, <a href=\"https:\/\/caixaresearch.org\/ca\/convocatoria-caixaresearch-investigacio-salut-2019-projecte-cancer-defenses\">Bruno Silva-Santos<\/a>, investigador de <a href=\"https:\/\/imm.medicina.ulisboa.pt\/\">l\u2019Instituto de Medicina Molecular (iMM)<\/a>, va compartir amb el p\u00fablic la seva pr\u00f2pia experi\u00e8ncia: \u00abLa nostra empresa va rebre prop de 300.000 euros de finan\u00e7ament a Portugal, per\u00f2 un cop adquirida per una empresa del Regne Unit, va atraure 2 milions d\u2019euros del primer inversor i immediatament es va crear un consell d\u2019administraci\u00f3, format per experts en diversos camps, per evitar que l\u2019empresa fracass\u00e9s. Al final, va rebre un finan\u00e7ament addicional de 98 milions d\u2019euros. L\u2019aportaci\u00f3 cient\u00edfica era \u00edntegrament portuguesa, per\u00f2 va ser l\u2019ecosistema brit\u00e0nic el que va permetre que prosper\u00e9s\u00bb. <strong>Aix\u00f2 subratlla la necessitat que Portugal desenvolupi un ecosistema s\u00f2lid que soni suport no sols a la recerca de qualitat, sin\u00f3 tamb\u00e9 a la transfer\u00e8ncia cient\u00edfica per mitj\u00e0 d\u2019un millor finan\u00e7ament i infraestructura<\/strong>.<\/p>\n<p><iframe loading=\"lazy\" title=\"YouTube video player\" src=\"https:\/\/www.youtube.com\/embed\/bvXjUV_4L7k?si=cOKsAeJRqWaxQ4HX\" width=\"400\" height=\"225\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<h3>2. La clau de la innovaci\u00f3 consisteix a trencar els grups estancs i mantenir la diversitat.<\/h3>\n<p>Com que molts dels reptes principals a qu\u00e8 ens enfrontem com a societat s\u00f3n estructurals, ens calen enfocaments, finan\u00e7ament i solucions estructurals per abordar-los. Malgrat aix\u00f2, aquests problemes estructurals solen ser tamb\u00e9 obstacles per obtenir resultats en recerca i innovaci\u00f3. Per resoldre aquests problemes, s\u2019han de trencar els grups estancs especialitzats i adoptar una visi\u00f3 m\u00e9s \u00e0mplia de la ci\u00e8ncia per posar al descobert noves connexions i enfocaments.<\/p>\n<p>\u00ab<strong>Les col\u00b7laboracions i associacions, tant entre entitats cient\u00edfiques com no cient\u00edfiques, s\u00f3n fonamentals per desenvolupar capacitats i aconseguir una massa cr\u00edtica<\/strong>\u00bb, va assenyalar Nuno Sousa, president de <a href=\"https:\/\/aicib.pt\/en\/inicio-aicib-english-2\/\">l\u2019Ag\u00eancia de Investiga\u00e7\u00e3o Cl\u00ednica e Inova\u00e7\u00e3o (AICIB)<\/a>. Aix\u00f2 \u00e9s especialment cert en un pa\u00eds com Portugal, amb una poblaci\u00f3 de tan sols 10 milions d\u2019habitants. No obstant aix\u00f2, al mateix temps tamb\u00e9 es fonamental mantenir la diversitat a trav\u00e9s de les aportacions individuals i la competitivitat. \u00ab<strong>Encara que Europa va despr\u00e9s de la Xina i els Estats Units pel que fa a producci\u00f3 cient\u00edfica, t\u00e9 una base de coneixements m\u00e9s s\u00f2lida i diversa que els seus hom\u00f2legs. Aix\u00f2 hauria de ser un crit d\u2019atenci\u00f3 per a Europa. Per maximitzar el seu impacte en innovaci\u00f3, Portugal ha d\u2019adoptar una perspectiva a escala de la UE en l\u2019\u00e0mbit de la innovaci\u00f3, i tamb\u00e9 ha de fomentar les diverses iniciatives en innovaci\u00f3 a escala local<\/strong>\u00bb, va explicar Manuel Heitor.<\/p>\n<p>Fins i tot a escala nacional i regional, \u00ab<strong>la col\u00b7laboraci\u00f3 i les fusions estrat\u00e8giques s\u00f3n importants, per\u00f2 les institucions portugueses tamb\u00e9 han d\u2019aplicar les seves pr\u00f2pies estrat\u00e8gies per garantir el progr\u00e9s constant de la diversitat d\u2019idees i innovacions del pa\u00eds<\/strong>\u00bb, va indicar <a href=\"https:\/\/caixaresearch.org\/ca\/convocatoria-caixaresearch-investigacio-salut-2023-projecte-plasmodium-malaria\">Mar\u00eda Mota<\/a>, presidenta executiva de <a href=\"https:\/\/gimm.pt\/\">l\u2019Instituto Gulbenkian de Medicina Molecular (GIMM)<\/a>.<\/p>\n<p><iframe loading=\"lazy\" title=\"YouTube video player\" src=\"https:\/\/www.youtube.com\/embed\/g0YZk3mTKaM?si=ceqdxImTB58mnxKy\" width=\"400\" height=\"225\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<h3>3. Cal tota una comunitat: la responsabilitat de la innovaci\u00f3 biom\u00e8dica ha de ser compartida.<\/h3>\n<p>Tradicionalment, s\u2019esperava que els cient\u00edfics no sols duguessin a terme investigacions, sin\u00f3 que tamb\u00e9 traslladessin els seus descobriments al mercat sense l\u2019ajuda de ning\u00fa. \u00abS\u2019espera dels cient\u00edfics que executin un gran nombre de funcions\u00bb, va dir <a href=\"https:\/\/caixaresearch.org\/ca\/convocatoria-caixaresearch-investigacio-salut-2022-projecte-biofarmacs-virus\">Cl\u00e1udio M. Soares<\/a>, de <a href=\"https:\/\/www.itqb.unl.pt\/\">l\u2019ITQB NOVA<\/a>. Tot i aix\u00ed, <strong>crear una empresa \u00e9s summament dif\u00edcil, i els cient\u00edfics necessiten molt m\u00e9s suport (tant financer com no financer) a l\u2019hora de posar en marxa les seves pr\u00f2pies empreses<\/strong>. Tal com va indicar Lorena Di\u00e9guez, \u00abjo em pensava que, si la ci\u00e8ncia era de qualitat, hi hauria alg\u00fa que es faria c\u00e0rrec del projecte i desenvoluparia una empresa emergent. Ara s\u00e9 que \u00e9s responsabilitat del cient\u00edfic crear un prototip i conv\u00e8ncer els possibles inversors. Sense iniciatives com la convocat\u00f2ria CaixaImpulse Innovaci\u00f3, molts projectes fracassarien a causa de l\u2019important finan\u00e7ament que cal entre la prova de concepte inicial i la inversi\u00f3 de capital risc\u00bb.<\/p>\n<p><strong>La comercialitzaci\u00f3 de la recerca biom\u00e8dica hauria de ser una responsabilitat compartida entre els cient\u00edfics, els sistemes de salut, la ind\u00fastria, les autoritats i altres parts interessades<\/strong>. \u00abHem de facilitar que els cient\u00edfics puguin transmetre els seus coneixements a les persones que siguin realment capaces d\u2019aplicar-los a trav\u00e9s d\u2019empreses productives\u00bb, va afirmar Nuno Sousa. Fins i tot molt abans que tercers entrin en escena, els centres de recerca han de proporcionar infraestructures per donar suport als investigadors interessats en l\u2019emprenedoria. \u00ab<strong>Les unitats de transfer\u00e8ncia tecnol\u00f2gica de les universitats hi tenen un paper fonamental; sense aquestes unitats, \u00e9s possible que els cient\u00edfics ni tan sols pensin en la comercialitzaci\u00f3 dels resultats de les seves investigacions. Si els investigadors saben que tenen suport institucional per orientar-los en relaci\u00f3 amb les sol\u00b7licituds, els passos i els processos, \u00e9s m\u00e9s probable que intentin transferir els seus resultats<\/strong>\u00bb, va explica Bruno Silva-Santos. Sempre hi hauria d\u2019haver alg\u00fa que desmitifiqu\u00e9s la complexitat del cam\u00ed que cal rec\u00f3rrer als futurs emprenedors i que els ajud\u00e9s a fer els passos necessaris. Els investigadors emprenedors amb experi\u00e8ncia podrien tenir un paper cabdal actuant com a mentors dels que estan iniciant el cam\u00ed o preveuen de fer-ho.<\/p>\n<p><iframe loading=\"lazy\" title=\"YouTube video player\" src=\"https:\/\/www.youtube.com\/embed\/IkR6Gn2I8wc?si=hKK9styE9uua4SdI\" width=\"400\" height=\"225\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<h3>4. Hem de donar als cient\u00edfics m\u00e9s oportunitats per formar-se en emprenedoria.<\/h3>\n<p>Els cient\u00edfics s\u00f3n innovadors per naturalesa, per\u00f2 tenen una formaci\u00f3 principalment investigadora, no empresarial. Per tant, <strong>\u00e9s essencial oferir-los la possibilitat de participar en programes de formaci\u00f3 intensius sobre transfer\u00e8ncia tecnol\u00f2gica que els permetin desenvolupar capacitats d\u2019emprenedoria, com el programa CaixaImpulse Innovaci\u00f3<\/strong>. La creaci\u00f3 d\u2019una cultura emprenedora ja ha de comen\u00e7ar en les primeres etapes educatives per tal de dotar els estudiants de les eines necess\u00e0ries per fomentar la innovaci\u00f3. <a href=\"https:\/\/caixaresearch.org\/ca\/convocatoria-caixaresearch-validate-2021-projecte-esterilitzacio-cateters\">In\u00eas C. Gon\u00e7alves<\/a>, de <a href=\"https:\/\/www.i3s.up.pt\/\">l\u2019Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade (i3S) | Instituto de Engenharia Biom\u00e9dica (INEB) de la Universidade do Porto<\/a>, va explicar la seva experi\u00e8ncia en aquest sentit: \u00abFa vint anys vaig fer un curs sobre emprenedoria que va transformar completament la meva visi\u00f3 de la ci\u00e8ncia. Des d\u2019aleshores, m\u2019he centrat sistem\u00e0ticament en la transfer\u00e8ncia dels resultats de les meves investigacions a aplicacions cl\u00edniques\u00bb. Aquest tipus de formaci\u00f3 tamb\u00e9 pot ajudar a combatre la fuga de cervells. \u00abMolts estudiants de doctorat portuguesos se\u2019n van a l\u2019estranger i ja no tornen, perqu\u00e8 les condicions i les oportunitats de desenvolupament i suport professional s\u00f3n millors en altres pa\u00efsos\u00bb, va dir Cl\u00e1udio M. Soares. Els cient\u00edfics volen tenir la llibertat de ser creatius, per\u00f2 tamb\u00e9 necessiten unes bones condicions i una infraestructura que els doni suport, tant si escullen ser emprenedors com si es decanten per un altre tipus de traject\u00f2ria professional.<\/p>\n<p><iframe loading=\"lazy\" title=\"YouTube video player\" src=\"https:\/\/www.youtube.com\/embed\/mgq0qGnT-IQ?si=QGdr41Dd3huP6Wmh\" width=\"400\" height=\"225\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<h3>5. La innovaci\u00f3 a llarg termini requereix una estrat\u00e8gia d\u2019inversi\u00f3 \u00e0mplia i sostinguda.<\/h3>\n<p>La innovaci\u00f3 a llarg termini dep\u00e8n de la inversi\u00f3 cont\u00ednua en investigaci\u00f3 b\u00e0sica. Encara que la transfer\u00e8ncia de tecnologia i les innovacions immediates s\u00f3n importants, els aut\u00e8ntics aven\u00e7os del futur depenen de la ci\u00e8ncia b\u00e0sica que es dugui a terme actualment. \u00ab<strong>El centre d\u2019aquest ecosistema \u00e9s la investigaci\u00f3 fonamental; no ho podem oblidar<\/strong>\u00bb, va afirmar Claudio Sunkel, director de l\u2019Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade (i3S) de la Universidade do Porto. \u00abCal ampliar el sistema per proporcionar el material que posteriorment es transferir\u00e0; si no hi ha primera mat\u00e8ria, no hi haur\u00e0 innovaci\u00f3\u00bb, va destacar <a href=\"https:\/\/caixaresearch.org\/ca\/convocatoria-caixaresearch-investigacio-salut-2019-projecte-sepsis\">Miguel C. Parreira Soares<\/a>, de <a href=\"https:\/\/gulbenkian.pt\/ciencia\/\">l\u2019Instituto Gulbenkian de Ci\u00eancia (IGC)<\/a>.<\/p>\n<p>\u00c0ngel Font, director executiu del <a href=\"https:\/\/fundacionlacaixa.org\/ca\/caixaresearch-institute\">CaixaResearch Institute<\/a> i d\u2019Investigaci\u00f3 i Salut a Portugal, va afegir: \u00abSense una ci\u00e8ncia de qualitat, no podem generar nous tractaments, tecnologies o solucions per als problemes m\u00e9s importants de la societat\u00bb.<\/p>\n<p>\u00ab\u00c9s important col\u00b7laborar estretament amb la ind\u00fastria i desenvolupar un full de ruta estrat\u00e8gic per als 10-20 anys vinents\u00bb, va indicar Catarina Resende de Oliveira, del <a href=\"https:\/\/cnc.uc.pt\/en\">Centro de Neuroci\u00eancias e Biologia Celular (CNC)<\/a> de la Universidade de Coimbra.<\/p>\n<p>Pedro Pita, que ocupa la C\u00e0tedra BPI\/Fundaci\u00f3 \u201dla Caixa\u201d d\u2019Economia de la Salut a la Nova School of Business and Economics, a c\u00e0rrec de la sessi\u00f3 d&#8217;acabament, va resumir els takeaways clau, va destacar la necessitat cr\u00edtica d\u2019abordar la fragmentaci\u00f3 del finan\u00e7ament que pateixen les diferents fases del proc\u00e9s d\u2019innovaci\u00f3 a Portugal. \u00abCom podem superar aquest problema? \u00c9s fonamental tenir una visi\u00f3 clara del cam\u00ed que s\u2019ha de seguir i assignar estrat\u00e8gicament els recursos, sempre limitats, entre els diferents grups i \u00e0rees de recerca. Ens cal un enfocament m\u00e9s estructurat, en comptes de confiar tan sols en la sort\u00bb, va indicar.<\/p>\n<p>\u00abEstablir fites que facilitin la col\u00b7laboraci\u00f3 entre els investigadors, els emprenedors i la ind\u00fastria \u00e9s essencial per estimular la innovaci\u00f3, i la col\u00b7laboraci\u00f3 entre el m\u00f3n acad\u00e8mic, la ind\u00fastria i les autoritats \u00e9s primordial per aconseguir-ho\u00bb, va concloure Joan Ramon Fuertes, director general adjunt de la Fundaci\u00f3 \u201dla Caixa\u201d.<\/p>\n<p>&nbsp;<\/p>\n<p><em>La innovaci\u00f3 nom\u00e9s es pot obrir pas si la fomentem entre tots. Per als nostres investigadors, la innovaci\u00f3 t\u00e9 a veure amb millorar la salut, generar valor per a la societat i transformar idees en solucions que salvin vides. Per a nosaltres \u00e9s ben clar: La innovaci\u00f3 consisteix a construir un futur millor per a tothom. Qu\u00e8 significa per a tu la innovaci\u00f3?<\/em><\/p>\n<p><iframe loading=\"lazy\" title=\"YouTube video player\" src=\"https:\/\/www.youtube.com\/embed\/3JRdrEp6RL4?si=zgvAcCn1_0NmwGwJ\" width=\"400\" height=\"225\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<p><em>La Fundaci\u00f3 \u201dla Caixa\u201d ha donat suport a la recerca i la innovaci\u00f3 en biomedicina i salut a Portugal des del 2017 a trav\u00e9s de les convocat\u00f2ries CaixaResearch d\u2019Investigaci\u00f3 en Salut i CaixaImpulse Innovaci\u00f3. En aquest v\u00eddeo pots descobrir l\u2019impacte que ha tingut:<\/em><\/p>\n<p><iframe loading=\"lazy\" title=\"YouTube video player\" src=\"https:\/\/www.youtube.com\/embed\/HKDlapMWsCY?si=62u_kIsEHiP841Qa\" width=\"400\" height=\"225\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n","protected":false},"excerpt":{"rendered":"<p><em>Catalan below<\/em><\/p>\n<p><iframe loading=\"lazy\" title=\"YouTube video player\" src=\"https:\/\/www.youtube.com\/embed\/oVfg1bsx18I?si=C5pKvwuz_FeoFn89\" width=\"400\" height=\"225\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<p>In recent years, the output from Portugal\u2019s biomedical research has been steadily increasing. However, the innovation ecosystem is still developing and there are diverse systemic challenges to overcome to ensure the efficient translation of biomedical research into clinical applications.<\/p>\n<p>On July 10, we organized an <a href=\"https:\/\/caixaresearch.org\/es\/innovation-day-portugal-introduction\">event<\/a> in Lisbon that brought together some of Portugal\u2019s top biomedical researchers and entrepreneurs, decision-makers and international experts to discuss the challenges and opportunities in bringing scientific discoveries from the lab to the clinic.<\/p>\n<p>The event, inaugurated by Artur Santos Silva, Member of the Board of Trustees of \u201dla Caixa\u201d Foundation and Fernando Alexandre, Portugal\u2019s Minister of Education,<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[340],"tags":[578],"class_list":["post-8597","post","type-post","status-publish","format-standard","hentry","category-sense-categoria","tag-investigacion-ca"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>5 key insights into the future of biomedical innovation in Portugal - Blog CaixaCi\u00e8ncia<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blog.caixaresearch.org\/ca\/5-key-insights-into-the-future-of-biomedical-innovation-in-portugal\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"5 key insights into the future of biomedical innovation in Portugal - Blog CaixaCi\u00e8ncia\" \/>\n<meta property=\"og:description\" content=\"Catalan below In recent years, the output from Portugal\u2019s biomedical research has been steadily increasing. However, the innovation ecosystem is still developing and there are diverse systemic challenges to overcome to ensure the efficient translation of biomedical research into clinical applications. On July 10, we organized an event in Lisbon that brought together some of Portugal\u2019s top biomedical researchers and entrepreneurs, decision-makers and international experts to discuss the challenges and opportunities in bringing scientific discoveries from the lab to the clinic. The event, inaugurated by Artur Santos Silva, Member of the Board of Trustees of \u201dla Caixa\u201d Foundation and Fernando Alexandre, Portugal\u2019s Minister of Education,\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blog.caixaresearch.org\/ca\/5-key-insights-into-the-future-of-biomedical-innovation-in-portugal\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog CaixaCi\u00e8ncia\" \/>\n<meta property=\"article:published_time\" content=\"2024-07-29T11:06:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-29T13:15:07+00:00\" \/>\n<meta name=\"author\" content=\"Ubikmedia\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ubikmedia\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"16 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/blog.caixaresearch.org\/ca\/5-key-insights-into-the-future-of-biomedical-innovation-in-portugal\/\",\"url\":\"https:\/\/blog.caixaresearch.org\/ca\/5-key-insights-into-the-future-of-biomedical-innovation-in-portugal\/\",\"name\":\"5 key insights into the future of biomedical innovation in Portugal - Blog CaixaCi\u00e8ncia\",\"isPartOf\":{\"@id\":\"https:\/\/blog.caixaresearch.org\/#website\"},\"datePublished\":\"2024-07-29T11:06:21+00:00\",\"dateModified\":\"2024-07-29T13:15:07+00:00\",\"author\":{\"@id\":\"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/2b9d5310c27055b4862191402c387fca\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/blog.caixaresearch.org\/ca\/5-key-insights-into-the-future-of-biomedical-innovation-in-portugal\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/blog.caixaresearch.org\/#website\",\"url\":\"https:\/\/blog.caixaresearch.org\/\",\"name\":\"Blog CaixaCi\u00e8ncia\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/blog.caixaresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/2b9d5310c27055b4862191402c387fca\",\"name\":\"Ubikmedia\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ccc66bc497f8ba496f9d06e5a58a91de?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ccc66bc497f8ba496f9d06e5a58a91de?s=96&d=mm&r=g\",\"caption\":\"Ubikmedia\"},\"url\":\"https:\/\/blog.caixaresearch.org\/ca\/author\/ubikmedia\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"5 key insights into the future of biomedical innovation in Portugal - Blog CaixaCi\u00e8ncia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blog.caixaresearch.org\/ca\/5-key-insights-into-the-future-of-biomedical-innovation-in-portugal\/","og_locale":"ca_ES","og_type":"article","og_title":"5 key insights into the future of biomedical innovation in Portugal - Blog CaixaCi\u00e8ncia","og_description":"Catalan below In recent years, the output from Portugal\u2019s biomedical research has been steadily increasing. However, the innovation ecosystem is still developing and there are diverse systemic challenges to overcome to ensure the efficient translation of biomedical research into clinical applications. On July 10, we organized an event in Lisbon that brought together some of Portugal\u2019s top biomedical researchers and entrepreneurs, decision-makers and international experts to discuss the challenges and opportunities in bringing scientific discoveries from the lab to the clinic. The event, inaugurated by Artur Santos Silva, Member of the Board of Trustees of \u201dla Caixa\u201d Foundation and Fernando Alexandre, Portugal\u2019s Minister of Education,","og_url":"https:\/\/blog.caixaresearch.org\/ca\/5-key-insights-into-the-future-of-biomedical-innovation-in-portugal\/","og_site_name":"Blog CaixaCi\u00e8ncia","article_published_time":"2024-07-29T11:06:21+00:00","article_modified_time":"2024-07-29T13:15:07+00:00","author":"Ubikmedia","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"Ubikmedia","Temps estimat de lectura":"16 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/blog.caixaresearch.org\/ca\/5-key-insights-into-the-future-of-biomedical-innovation-in-portugal\/","url":"https:\/\/blog.caixaresearch.org\/ca\/5-key-insights-into-the-future-of-biomedical-innovation-in-portugal\/","name":"5 key insights into the future of biomedical innovation in Portugal - Blog CaixaCi\u00e8ncia","isPartOf":{"@id":"https:\/\/blog.caixaresearch.org\/#website"},"datePublished":"2024-07-29T11:06:21+00:00","dateModified":"2024-07-29T13:15:07+00:00","author":{"@id":"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/2b9d5310c27055b4862191402c387fca"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blog.caixaresearch.org\/ca\/5-key-insights-into-the-future-of-biomedical-innovation-in-portugal\/"]}]},{"@type":"WebSite","@id":"https:\/\/blog.caixaresearch.org\/#website","url":"https:\/\/blog.caixaresearch.org\/","name":"Blog CaixaCi\u00e8ncia","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blog.caixaresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Person","@id":"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/2b9d5310c27055b4862191402c387fca","name":"Ubikmedia","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ccc66bc497f8ba496f9d06e5a58a91de?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ccc66bc497f8ba496f9d06e5a58a91de?s=96&d=mm&r=g","caption":"Ubikmedia"},"url":"https:\/\/blog.caixaresearch.org\/ca\/author\/ubikmedia\/"}]}},"_links":{"self":[{"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/posts\/8597","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/comments?post=8597"}],"version-history":[{"count":7,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/posts\/8597\/revisions"}],"predecessor-version":[{"id":8608,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/posts\/8597\/revisions\/8608"}],"wp:attachment":[{"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/media?parent=8597"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/categories?post=8597"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/tags?post=8597"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}